{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for mmae in Protein Structural Modification Substance Name (approximate match)
Status:
US Approved Rx
(2021)
Source:
BLA761208
(2021)
Source URL:
First approved in 2021
Source:
BLA761208
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2019)
Source:
BLA761137
(2019)
Source URL:
First approved in 2019
Source:
BLA761137
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2019)
Source:
BLA761121
(2019)
Source URL:
First approved in 2019
Source:
BLA761121
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2011)
Source:
BLA125399
(2011)
Source URL:
First approved in 2011
Source:
BLA125399
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sigvotatug vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:samrotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:zilovertamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mecbotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:disitamab vedotin [INN]
Source URL:
Class:
PROTEIN
